ORMP - Oramed Pharmaceuticals Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ORMP (1176309)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2023-04-03
ORMPMayer ArieDirP - Purchase$2.22+8,80926,809+49%+$19,518
2023-03-16
ORMPKidron NadavPres, CEOP - Purchase$2.04+26,0001,179,098+2%+$53,014
2023-03-14
ORMPKidron NadavPres, CEOP - Purchase$2.01+100,0001,153,098+9%+$201,000
2023-03-14
ORMPKidron MiriamChief Scientific OfficerS - Sale$2.01-100,000201,666-33%-$201,000
M
2023-03-13
ORMPRozov YadinDirP - Purchase$2.02+70,00086,500+424%+$141,570
2023-01-03
ORMPRabinowitz MichaelChief Commercial OfficerS - Sale$12.55-13,325126,143-10%-$167,195

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top